Hadi Karami1, Behzad Baradaran2, Ali Esfahani3, Masoud Sakhinia4, Ebrahim Sakhinia5. 1. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ; Department of Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. 2. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 3. Hematology and Oncology Research Center, Shahid Ghazi Hospital, Tabriz University of Medical Sciences, Tabriz, Iran. 4. Faculty of Medicine, University of Liverpool, Liverpool, United Kingdom. 5. Department of Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. ; Tuberculosis and Lung Disease Reseach Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
PURPOSE: Up-regulation of Mcl-1, a known anti-apoptotic protein, is associated with the survival and progression of various malignancies including leukemia. The aim of this study was to explore the effect of Mcl-1 small interference RNA (siRNA) on the proliferation and apoptosis of HL-60 acute myeloid leukemia (AML) cells. METHODS: siRNA transfection was performed using Lipofectamine™2000 reagent. Relative mRNA and protein expressions were quantified by quantitative real-time PCR and Western blotting, respectively. Trypan blue assay was performed to assess tumor cell proliferation after siRNA transfection. The cytotoxic effect of Mcl-1 siRNA on leukemic cells was measured using MTT assay. Apoptosis was detected using ELISA cell death assay. RESULTS: Mcl-1 siRNA clearly lowered both Mcl-1 mRNA and protein levels in a time-dependent manner, leading to marked inhibition of cell survival and proliferation. Furthermore, Mcl-1 down-regulation significantly enhanced the extent of HL-60 apoptotic cells. CONCLUSION: Our results suggest that the down-regulation of Mcl-1 by siRNA can effectively trigger apoptosis and inhibit the proliferation of leukemic cells. Therefore, Mcl-1 siRNA may be a potent adjuvant in AML therapy.
PURPOSE: Up-regulation of Mcl-1, a known anti-apoptotic protein, is associated with the survival and progression of various malignancies including leukemia. The aim of this study was to explore the effect of Mcl-1 small interference RNA (siRNA) on the proliferation and apoptosis of HL-60 acute myeloid leukemia (AML) cells. METHODS: siRNA transfection was performed using Lipofectamine™2000 reagent. Relative mRNA and protein expressions were quantified by quantitative real-time PCR and Western blotting, respectively. Trypan blue assay was performed to assess tumor cell proliferation after siRNA transfection. The cytotoxic effect of Mcl-1 siRNA on leukemic cells was measured using MTT assay. Apoptosis was detected using ELISA cell death assay. RESULTS:Mcl-1 siRNA clearly lowered both Mcl-1 mRNA and protein levels in a time-dependent manner, leading to marked inhibition of cell survival and proliferation. Furthermore, Mcl-1 down-regulation significantly enhanced the extent of HL-60 apoptotic cells. CONCLUSION: Our results suggest that the down-regulation of Mcl-1 by siRNA can effectively trigger apoptosis and inhibit the proliferation of leukemic cells. Therefore, Mcl-1 siRNA may be a potent adjuvant in AML therapy.
Authors: Tomas Kupsa; Jan Milos Horacek; Ladislav Jebavy Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Date: 2012-12-07 Impact factor: 1.245
Authors: Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer Journal: Nature Date: 2003-12-11 Impact factor: 49.962
Authors: Muhammed H Rahaman; Yingyi Yu; Longjin Zhong; Julian Adams; Frankie Lam; Peng Li; Ben Noll; Robert Milne; Jun Peng; Shudong Wang Journal: Invest New Drugs Date: 2018-09-08 Impact factor: 3.850
Authors: Saiedeh Razi Soofiyani; Akbar Mohammad Hoseini; Ali Mohammadi; Vahid Khaze Shahgoli; Behzad Baradaran; Mohammad Saeid Hejazi Journal: Adv Pharm Bull Date: 2017-12-31